Laserfiche WebLink
f 1 <br />0 <br />State of California -Health and Welfare Agency <br />P <br />v <br />.,� �• - .ff Mr. 72 <br />Departrnent of Health Services <br />Page 2 of 7 pages <br />License Number. 1812-3 <br />6. Nuclide <br />7. Form <br />8. Possession Limit <br />F. Group 6 as specified in <br />F. <br />F. <br />Item 9. <br />1. Cesium 137 <br />1. Sealed source <br />1. Total 250 mCi, no single source <br />to exceed 20 mCi. <br />2. Gold 198 <br />2. Seeds <br />2. 200 mCi <br />3. Iodine 125 <br />3. Seeds <br />3. 400 mCi <br />4. Iridium 192 <br />4. Seeds <br />4. 400 mCi <br />5. Palladium 103 <br />5. Seeds <br />5. 400 mCi <br />6. Strontium 90 <br />6. Applicator <br />6. Total 100 mCi, no single source <br />to exceed 100 mCi. <br />G. Group 9 as specified in <br />G. Sealed or solid sources <br />G. Total not to exceed 25 mCi. <br />Item 9. <br />manufactured in accordance with <br />a specific license issued by the <br />Each source not to exceed 15 mCi. <br />Any radionuclide with <br />United States Nuclear <br />atomic number 3-83 <br />Regulatory Commission or an <br />inclusive, except: <br />Agreement State. <br />Strontium 90 and <br />Lead 210 <br />9. Authorized Use <br />To be used for nuclear medicine procedures as specified in the groups below. <br />A. Group 1 Diagnostic studies involving measurement of uptake, dilution, or excretion but not involving <br />imaging. <br />B. Group 2 Diagnostic studies involving imaging including the use of Xenon 127 and/or Xenon 133 gas. <br />C. Group 3 Reagent kits including Mo/Tc 99m and Rb/Kr 81m generators and utilizing bulk technetium <br />prepared by a radiopharmacy for preparation of radiopharmaceuticals listed in Group 2. <br />D. Group 4 Internal therapy not usually requiring hospitalization. <br />E. Group 5 Internal therapy requiring hospitalization for purposes of radiation safety. <br />